차세대 종양학 기기 및 솔루션 시장 규모는 향후 몇 년 동안 18.6%의 연평균 성장률을 기록하며 2029년까지 327억 3,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 세계 인구의 고령화, 종양학 스타트업에 대한 투자 증가, 의료비 상승, 비침습적 또는 최소침습적 진단에 대한 수요 증가, 의료 인프라 개발로 인해 발생할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 AI를 활용한 영상 진단, 액체 생검의 발전, 맞춤형 의료 플랫폼, 웨어러블 건강 모니터링 기기, 로봇 공학, 최소침습 수술 도구 등이 있습니다.
암의 유병률 증가는 차세대 종양학 기기 및 솔루션 시장의 성장을 촉진할 것으로 예상됩니다. 암은 비정상적인 세포의 통제할 수 없는 증식을 특징으로 하는 질병으로, 신체의 다른 부위로 퍼져 정상적인 기능을 파괴할 수 있습니다. 암의 유병률 증가는 주로 인구의 고령화에 기인하며, 암 발병 위험은 나이가 들수록 증가하기 때문입니다. 차세대 종양학 기기 및 솔루션은 조기 발견, 보다 정확한 진단, 맞춤형 치료를 가능하게함으로써 이러한 증가에 대응할 수 있도록 돕습니다. 예를 들어, 미국 비영리단체인 미국암협회는 2024년 1월 미국 내 암으로 인한 사망자 수가 61만 1,000명을 넘어설 것으로 예상하고 있으며, 이는 하루 1,600명 이상에 해당합니다. 이처럼 암 유병률의 증가는 차세대 종양학 기기 및 솔루션 시장의 성장에 중요한 촉진제 역할을 하고 있습니다.
차세대 종양학 기기 및 솔루션 시장의 주요 기업들은 차세대 염기서열 분석(NGS) 표적 농축 솔루션과 같은 기술 혁신에 집중하여 희귀 유전자 변이 검출을 개선하고, 염기서열 분석의 정확도를 높이며, 암 진단 및 치료 방침을 보다 신속하게 결정할 수 있도록 노력하고 있습니다. 솔루션은 특정 DNA 또는 RNA 영역을 선택적으로 포착하고 농축하여 암 및 기타 질병과 관련된 유전자 변이를 보다 정확하고 효율적으로 분석할 수 있도록 하는 기술입니다. 예를 들어, 2025년 4월 미국 생명공학 기업 Integrated DNA Technologies(IDT)는 NGS 워크플로우를 간소화하여 암 연구를 가속화하기 위해 고안된 첨단 하이브리드화 캡처 솔루션인 xGen Hybridization and Wash v3 Kit를 출시했습니다. 이 키트는 하이브리드화 시간을 1시간으로 단축시켜 연구자들이 샘플 조제부터 시퀀싱까지 한 번의 작업으로 완료할 수 있도록 돕습니다. 이 솔루션은 가열 버퍼의 필요성을 없애고 작업 시간을 20% 단축하여 고도의 자동화에 적합하며, 하이스루풋 애플리케이션에 이상적입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 차세대 종양학 기기 및 솔루션 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 성장률 분석
- 세계의 차세대 종양학 기기 및 솔루션 시장 규모·성장률 : 실적치, 2019-2024년
- 세계의 차세대 종양학 기기 및 솔루션 시장 규모·성장률 : 예측치, 2024-2029년, 2034년
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 전체 시장(TAM)
제6장 시장 세분화
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 암 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 유방암
- 자궁경부암
- 대장암
- 폐암
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 기술별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 차세대 시퀀싱(NGS)
- 중합효소 연쇄 반응(PCR)
- DNA 마이크로어레이
- 다중화
- 기타 기술
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 용도별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 스크리닝·조기 발견
- 예측·모니터링
- 치료법 선택
- 재발 모니터링
- 기타 용도
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 최종 용도별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 병원과 진료소
- 진단 검사실
- 학술연구기관
- 기타 최종사용자
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 유방암 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 침윤성 유관암
- 침윤성 소엽암
- 삼중음성 유방암
- HER2 양성 유방암
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 자궁경부암 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 편평상피암
- 선암
- 선편평상피암
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 대장암 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 대장암
- 직장암
- 전이성 대장암
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 폐암 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 비소세포폐암(NSCLC)
- 소세포폐암(SCLC)
- 폐선암
- 편평상피폐암
제7장 지역별·국가별 분석
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 지역별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 세계의 차세대 종양학 기기 및 솔루션 시장 : 국가별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 차세대 종양학 기기 및 솔루션 시장 : 경쟁 구도
- 차세대 종양학 기기 및 솔루션 시장 : 기업 개요
- Johnson & Johnson Services Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
- Siemens AG(개요, 제품 및 서비스, 전략, 재무 분석)
- Merck & Co. Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
- Thermo Fisher Scientific Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
- Novartis AG(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업과 혁신적 기업
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Agilent Technologies Inc.
- Illumina Inc.
- Sysmex Corporation
- QIAGEN N.V.
- Exact Sciences Corporation
- Elekta AB
- Myriad Genetics Inc.
- Takara Bio USA Inc.
- NeoGenomics Inc.
- Guardant Health Inc.
- Accuray Incorporated
- SOPHiA GENETICS SA
- Paige.AI Inc.
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업 인수합병(M&A)
제34장 최근의 시장 동향
제35장 시장 잠재력 높은 나라·부문과 전략
- 차세대 종양학 기기 및 솔루션 시장 : 최신 기회를 제공하는 국가(2029년)
- 차세대 종양학 기기 및 솔루션 시장 : 최신 기회를 제공하는 부문(2029년)
- 차세대 종양학 기기 및 솔루션 시장 : 성장 전략(2029년)
제36장 부록
ksm
Next-generation oncology devices and solutions encompass advanced technologies and tools developed to detect, diagnose, monitor, and treat various forms of cancer with enhanced precision and speed. Their goal is to facilitate personalized cancer care by utilizing innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes.
The primary cancer types addressed by next-generation oncology devices and solutions include breast cancer, cervical cancer, colorectal cancer, and lung cancer. Breast cancer is a condition where cells in the breast grow uncontrollably, often forming a tumor that can be felt as a lump or identified through imaging. These solutions employ technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA microarrays, multiplexing, and other advanced techniques, which are applied in areas such as screening and early detection, prognostics and monitoring, therapy selection, and recurrence monitoring. The key end users include hospitals and clinics, diagnostic laboratories, academic and research institutions, and more.
The next-generation oncology devices and solutions market research report is one of a series of new reports from The Business Research Company that provides next-generation oncology devices and solutions market statistics, including the next-generation oncology devices and solutions industry global market size, regional shares, competitors with the next-generation oncology devices and solutions market share, detailed next-generation oncology devices and solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the next-generation oncology devices and solutions industry. This next-generation oncology devices and solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $13.90 billion in 2024 to $16.52 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth observed in the historical period can be attributed to the increasing global cancer incidence, expansion of oncology research and clinical trials, advancements in precision medicine, growth of hospital and diagnostic infrastructure, and greater awareness of early cancer screening.
The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $32.73 billion in 2029 at a compound annual growth rate (CAGR) of 18.6%. The growth anticipated in the forecast period is driven by the aging global population, increased investment in oncology startups, rising healthcare expenditures, greater demand for non-invasive or minimally invasive diagnostics, and the development of healthcare infrastructures. Key trends in the forecast period include AI-powered diagnostic imaging, advancements in liquid biopsy, personalized medicine platforms, wearable health monitoring devices, robotics, and minimally invasive surgical tools.
The growing prevalence of cancer is expected to drive the expansion of the next-generation oncology devices and solutions market. Cancer is a disease characterized by uncontrolled growth of abnormal cells, which can spread to other areas of the body, disrupting normal functions. The increasing prevalence of cancer is mainly due to aging populations, as the risk of developing cancer rises with age. Next-generation oncology devices and solutions help address this rise by enabling earlier detection, more accurate diagnosis, and personalized treatment. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization, estimated that cancer would cause over 611,000 deaths in the United States, which equals more than 1,600 cancer-related deaths per day. As such, the growing prevalence of cancer is a key driver for the growth of the next-generation oncology devices and solutions market.
Leading companies in the next-generation oncology devices and solutions market are focusing on technological innovations, such as next-generation sequencing (NGS) target enrichment solutions, to improve the detection of rare genetic variants, enhance sequencing accuracy, and expedite cancer diagnosis and treatment decisions. NGS target enrichment solutions involve techniques that selectively capture and concentrate specific DNA or RNA regions for sequencing, allowing more precise and efficient analysis of genetic variants associated with cancer and other diseases. For instance, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, launched the xGen Hybridization and Wash v3 Kit, an advanced hybridization capture solution designed to accelerate cancer research by streamlining NGS workflows. This kit reduces hybridization time to just one hour, enabling researchers to complete sample preparation and sequencing in a single workday. By eliminating the need for heated buffers and cutting hands-on time by 20%, the solution is highly automation-friendly and ideal for high-throughput applications.
In July 2024, Hologic, a US-based medical technology company, acquired Endomag for an undisclosed amount. This acquisition aims to enhance Hologic's breast cancer surgery portfolio by incorporating Endomag's innovative surgical guidance products, which improve the precision and effectiveness of cancer care. Endomag, a UK-based medical device manufacturer, specializes in surgical guidance products for breast cancer treatment.
Major players in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., and Lucida Medical Ltd.
North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in next-generation oncology devices and solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the next-generation oncology devices and solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The next-generation oncology devices and solutions market consists of revenues earned by entities by providing services such as cancer genomic profiling and sequencing, personalized treatment planning, remote patient monitoring and tele-oncology, and early cancer detection and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation oncology devices and solutions market also includes sales of liquid biopsy kits, companion diagnostic tests, digital pathology systems, cancer biomarker detection assays, and targeted therapy monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Next-Generation Oncology Devices And Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on next-generation oncology devices and solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for next-generation oncology devices and solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The next-generation oncology devices and solutions market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Cancer Type: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer
- 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); DNA Microarrays; Multiplexing; Other Technologies
- 3) By Application: Screening And Early Detection; Prognostics And Monitoring; Therapy Selection; Recurrence Monitoring; Other Applications
- 4) By End Use: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Uses
- Subsegments:
- 1) By Breast Cancer: Invasive Ductal Carcinoma; Invasive Lobular Carcinoma; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer
- 2) By Cervical Cancer: Squamous Cell Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
- 3) By Colorectal Cancer: Colon Cancer; Rectal Cancer; Metastatic Colorectal Cancer
- 4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC); Lung Adenocarcinoma; Squamous Cell Lung Carcinoma
- Companies Mentioned: Johnson & Johnson Services Inc.; Siemens AG; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Novartis AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Next-Generation Oncology Devices And Solutions Market Characteristics
3. Next-Generation Oncology Devices And Solutions Market Trends And Strategies
4. Next-Generation Oncology Devices And Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Next-Generation Oncology Devices And Solutions Growth Analysis And Strategic Analysis Framework
- 5.1. Global Next-Generation Oncology Devices And Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Next-Generation Oncology Devices And Solutions Market Growth Rate Analysis
- 5.4. Global Next-Generation Oncology Devices And Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Next-Generation Oncology Devices And Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Next-Generation Oncology Devices And Solutions Total Addressable Market (TAM)
6. Next-Generation Oncology Devices And Solutions Market Segmentation
- 6.1. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Lung Cancer
- 6.2. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- DNA Microarrays
- Multiplexing
- Other Technologies
- 6.3. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Screening And Early Detection
- Prognostics And Monitoring
- Therapy Selection
- Recurrence Monitoring
- Other Applications
- 6.4. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Diagnostic laboratories
- Academic And Research Institutions
- Other End Users
- 6.5. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Invasive Ductal Carcinoma
- Invasive Lobular Carcinoma
- Triple-Negative Breast Cancer
- HER2-Positive Breast Cancer
- 6.6. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Squamous Cell Carcinoma
- Adenocarcinoma
- Adenosquamous Carcinoma
- 6.7. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Colon Cancer
- Rectal Cancer
- Metastatic Colorectal Cancer
- 6.8. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Lung Adenocarcinoma
- Squamous Cell Lung Carcinoma
7. Next-Generation Oncology Devices And Solutions Market Regional And Country Analysis
- 7.1. Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Next-Generation Oncology Devices And Solutions Market
- 8.1. Asia-Pacific Next-Generation Oncology Devices And Solutions Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Next-Generation Oncology Devices And Solutions Market
- 9.1. China Next-Generation Oncology Devices And Solutions Market Overview
- 9.2. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Next-Generation Oncology Devices And Solutions Market
- 10.1. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Next-Generation Oncology Devices And Solutions Market
- 11.1. Japan Next-Generation Oncology Devices And Solutions Market Overview
- 11.2. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Next-Generation Oncology Devices And Solutions Market
- 12.1. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Next-Generation Oncology Devices And Solutions Market
- 13.1. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Next-Generation Oncology Devices And Solutions Market
- 14.1. South Korea Next-Generation Oncology Devices And Solutions Market Overview
- 14.2. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Next-Generation Oncology Devices And Solutions Market
- 15.1. Western Europe Next-Generation Oncology Devices And Solutions Market Overview
- 15.2. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Next-Generation Oncology Devices And Solutions Market
- 16.1. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Next-Generation Oncology Devices And Solutions Market
- 17.1. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Next-Generation Oncology Devices And Solutions Market
- 18.1. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Next-Generation Oncology Devices And Solutions Market
- 19.1. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Next-Generation Oncology Devices And Solutions Market
- 20.1. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Next-Generation Oncology Devices And Solutions Market
- 21.1. Eastern Europe Next-Generation Oncology Devices And Solutions Market Overview
- 21.2. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Next-Generation Oncology Devices And Solutions Market
- 22.1. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Next-Generation Oncology Devices And Solutions Market
- 23.1. North America Next-Generation Oncology Devices And Solutions Market Overview
- 23.2. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Next-Generation Oncology Devices And Solutions Market
- 24.1. USA Next-Generation Oncology Devices And Solutions Market Overview
- 24.2. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Next-Generation Oncology Devices And Solutions Market
- 25.1. Canada Next-Generation Oncology Devices And Solutions Market Overview
- 25.2. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Next-Generation Oncology Devices And Solutions Market
- 26.1. South America Next-Generation Oncology Devices And Solutions Market Overview
- 26.2. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Next-Generation Oncology Devices And Solutions Market
- 27.1. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Next-Generation Oncology Devices And Solutions Market
- 28.1. Middle East Next-Generation Oncology Devices And Solutions Market Overview
- 28.2. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Next-Generation Oncology Devices And Solutions Market
- 29.1. Africa Next-Generation Oncology Devices And Solutions Market Overview
- 29.2. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Company Profiles
- 30.1. Next-Generation Oncology Devices And Solutions Market Competitive Landscape
- 30.2. Next-Generation Oncology Devices And Solutions Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Next-Generation Oncology Devices And Solutions Market Other Major And Innovative Companies
- 31.1. Koninklijke Philips N.V.
- 31.2. GE HealthCare Technologies Inc.
- 31.3. Agilent Technologies Inc.
- 31.4. Illumina Inc.
- 31.5. Sysmex Corporation
- 31.6. QIAGEN N.V.
- 31.7. Exact Sciences Corporation
- 31.8. Elekta AB
- 31.9. Myriad Genetics Inc.
- 31.10. Takara Bio USA Inc.
- 31.11. NeoGenomics Inc.
- 31.12. Guardant Health Inc.
- 31.13. Accuray Incorporated
- 31.14. SOPHiA GENETICS SA
- 31.15. Paige.AI Inc.
32. Global Next-Generation Oncology Devices And Solutions Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market
34. Recent Developments In The Next-Generation Oncology Devices And Solutions Market
35. Next-Generation Oncology Devices And Solutions Market High Potential Countries, Segments and Strategies
- 35.1 Next-Generation Oncology Devices And Solutions Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Next-Generation Oncology Devices And Solutions Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Next-Generation Oncology Devices And Solutions Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
